Generic Name: HYDROCODONE/IBUPROFEN - ORAL Pronounced: (HYE-droe-KOE-done/EYE-bue-proe-fen) Hydrocodone-Ibuprofen Oral Interactions
Drug interactions may change how your medications work or
increase your risk for serious side effects. This document does not contain all
possible drug interactions. Keep a list of all the products you use (including
prescription/nonprescription drugs and herbal products) and share it with your
doctor and pharmacist. Do not start, stop, or change the dosage of any
medicines without your doctor's approval.
Some products that may interact with this drug
aspirin or other NSAIDs (such as ketorolac,
anti-platelet drugs (such as cilostazol,
bisphosphonates taken by mouth (such as
"blood thinners" (such as enoxaparin, heparin,
corticosteroids (such as prednisone)
MAO inhibitors (isocarboxazid, linezolid, methylene blue,
I was reading through the MyRACentral News Page the other day and an article about Celebrex caught my eye. Celebrex is a non-steroidal anti-inflammatory (NSAID) in the COX-2 inhibitor family. A similar drug, Vioxx, manufactured by rival company Merck, was withdrawn from the market in September 2004 because of increased risk of serious blood clotting, heart attacks and strokes. Three months later the FDA asked Pfizer to voluntarily stop all direct-to-consumer advertising of Celebrex. A few months later, Pfizer also pulled its drug, Bextra, from the market in early 2005, because of a link to a serious skin disorder. Although Pfizer has not advertised, Celebrex has remained on the market because the FDA determined that the benefits of the drug outweigh the significant risks. I haven’t seen the new media or print ads yet, but I think the new spin on the risks that is discussed in the news article is interesting. Apparently, Pfizer begins the...
On Thursday, April 12 an FDA advisory panel will discuss
whether or not to recommend that the FDA approve Merck & Co’s COX-2
inhibitor, Arcoxia (etoricoxib). The drug is manufactured by Merck, the
same company that made Vioxx, which was pulled from the market in the fall of
2004. Merck applied for approval to sell Arcoxia as a treatment for the
signs and symptoms of osteoarthritis .
Currently, the only COX-2 inhibitor remaining on the market
is Celebrex , made by Pfizer, Inc. These COX-2 inhibitors are all types of
NSAIDs. Over the counter types of NSAIDs include naproxen (sold as Aleve)
and ibuprofen. The difference between the prescription COX-2s and the OTC
NSAIDS (and the big selling point) is that the COX-2s have a lower risk of
bleeding ulcers and other GI complications than other NSAIDs. However,
studies have shown that the COX-2s have a higher risk of heart attack and
strokes. Vioxx and Bextra were both subsequently...
You should knowAnswers to your question are meant to provide general health information but should not replace medical advice you receive from a doctor. No answers should be viewed as a diagnosis or recommended treatment for a condition. Content posted by community members does not necessarily reflect the views of Remedy Health Media, which also reserves the right to remove material deemed inappropriate.